It is worth mentioning that glioblastoma cell lines used in the study exhibit alterations of TP53, PTEN genes and deletions of cell cycle suppressors p16/CDKN2A and p14ARF genes [12]. This evidence concerns the gene CDKN2A and glioblastoma.